1. Home
  2. XTNT vs BENF Comparison

XTNT vs BENF Comparison

Compare XTNT & BENF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

HOLD

Current Price

$0.44

Market Cap

61.7M

Sector

Health Care

ML Signal

HOLD

Logo Beneficient

BENF

Beneficient

HOLD

Current Price

$3.40

Market Cap

51.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
XTNT
BENF
Founded
N/A
2003
Country
United States
United States
Employees
N/A
55
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
61.7M
51.4M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
XTNT
BENF
Price
$0.44
$3.40
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.00
N/A
AVG Volume (30 Days)
103.2K
15.3K
Earning Date
05-08-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
125.00
N/A
EPS
N/A
N/A
Revenue
$53,337,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.30
$30.01
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$0.27
52 Week High
$0.95
$9.96

Technical Indicators

Market Signals
Indicator
XTNT
BENF
Relative Strength Index (RSI) 38.46 45.95
Support Level $0.44 $3.16
Resistance Level $0.48 $3.59
Average True Range (ATR) 0.02 0.22
MACD 0.00 -0.02
Stochastic Oscillator 48.72 29.85

Price Performance

Historical Comparison
XTNT
BENF

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

About BENF Beneficient

Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and a financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.

Share on Social Networks: